Article

jdsupra.com on 2018-03-19 20:43

Amgen’s Motion to Dismiss Genentech’s Complaint in the Delaware Mvasi Litigation

As we previously reported, Genentech has filed two pending cases (Case Nos. 1:17-cv-01407 and 1:17-cv-01471) in the District of Delaware related to ...

Delaware

Related news

Litigation Update: Genentech’s Motion to Dismiss Amgen’s Counterclaims Denied in Avastin Biosimilar Litigation jdsupra.com
California , United States , Switzerland
Court Grants Amgen’s Motion To Dismiss Genentech’s Declaratory Judgment Counts in Mvasi™ Litigation, and Sets June 2020 Trial Date jdsupra.com
Delaware , Cranz
Court Denies Amgen’s Motion to Dismiss and Motion to Stay Regeneron’s Antitrust Case jdsupra.com
Delaware
Delaware District Court Adopts Magistrate Judge’s Report and Recommendation Denying Amgen’s Motion to Dismiss Regeneron’s Antitrust Claims, Overruling Amgen’s Objections jdsupra.com
Delaware
Analysis of Amgen’s complaint against Sandoz in pegfilgrastim litigation jdsupra.com
New Jersey , California
CD Cal Stays Dismissal of Amgen DJ Complaint Pending Delaware Decision on Genentech’s Motion to Transfer in MVASI® litigation jdsupra.com
California , Delaware , Manage
District Court Applies Mayo To Treatment Claims But Denies Motion To Dismiss BMS Keytruda Litigation jdsupra.com
Delaware
Genentech Seeks to Dismiss and Strike Amgen’s Counterclaims and Certain Defenses in Bevacizumab Biosimilar Litigation jdsupra.com
California , United States , Switzerland
Judge Sleet Grants Amgen’s Motion To Dismiss Genetech’s Commercial Marketing Claim Without Prejudice jdsupra.com
Cranz
Delaware judge rejects Fox News motion to dismiss lawsuit Seattle Times
Venezuela , Delaware
Delaware Federal Court Grants RMBS Trustee’s Motion to Dismiss jdsupra.com